Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2025)
Pulmonx (LUNG) posted quarterly Total Non-Current Liabilities of $75.2 million for Q4 2025, up 94.15% quarter-over-quarter from $38.7 million in Q3 2022.
Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Total Non-Current Liabilities for 5 consecutive years, with $75.2 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Non-Current Liabilities changed N/A year-over-year to $75.2 million; the TTM figure through Dec 2025 stood at $75.2 million (changed N/A YoY), while the FY2025 annual figure was $75.2 million, changed N/A from the prior year.
- Total Non-Current Liabilities grew to $75.2 million in Q4 2025 per LUNG's latest filing, from $38.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $75.2 million in Q4 2025 and bottomed at $38.7 million in Q3 2022.
- Historically, Total Non-Current Liabilities has averaged $47.3 million across 3 years, with a median of $40.5 million in 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Pulmonx | 93.95 Mn | 24.20 Mn | - | 75.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75.18 Mn |
| Sep 30, 2022 | 38.72 Mn |
| Jun 30, 2022 | 40.37 Mn |
| Mar 31, 2022 | 40.53 Mn |
| Dec 31, 2021 | 41.76 Mn |
| Sep 30, 2020 | 68.63 Mn |
| Dec 31, 2019 | 34.37 Mn |